The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Continue » The leader in diabetes and obesity Despite Lilly's huge success in treating diabetes and obesity, it's not the ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Officers went undercover to buy drugs, including methamphetamine and fentanyl, in order to catch the alleged sellers prior to ...

EXCLUSIVE: Successfully ridding the U.S. of the effects of Mexico's criminal cartels operating along the southwestern border ...

EXCLUSIVE: Sens. Ron Johnson and Chuck Grassley are demanding information from the Justice Department’s inspector general on whether any unassigned, or "untasked," confidential human sources from DOJ ...

Reese Marketos played the role of government prosecutor in a False Claims Act case about alleged off-label use of an HIV drug ...

Stocks to Watch. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other ...

While J&J expects tariffs will cost it $400 million this year, the company maintained its earnings estimate and upped its ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.